Medical News

RSS

Disease burden from air pollution underestimated, U.N. reports

"Air pollution is an underestimated scourge that kills far more people than AIDS and malaria and a shift to cleaner energy could easily halve the toll by 2030, U.N. officials said on Tuesday" at a conference in Oslo focusing on new development goals for the post-2015 development agenda, Reuters reports.

11 Apr 2013

Global health efforts a casualty of across-the-board cuts under 'sequester'

"The across-the-board cuts under the 'sequester' will undermine efficient programs, along with the inefficient. One unfortunate casualty is spending on global health efforts," a Pittsburgh Post-Gazette editorial says.

11 Apr 2013

Survey shows San Diego County drivers are distracted

According to experts in the Training, Research and Education for Driving Safety program at the University of California, San Diego School of Medicine, there were approximately 3,300 deaths and 400,000 injuries nationwide in 2011 due to collisions involving distracted driving.

11 Apr 2013

Lipid Therapeutics to proceed with US LT-02 Phase III trial for mild-moderate ulcerative colitis

Lipid Therapeutics announces today that it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed with a planned Phase III trial in the US in mild-moderate ulcerative colitis patients. The LT-02 IND was subject to the FDA's customary 30 day review period.

11 Apr 2013

First Edition: April 11, 2013

Today's headlines include details regarding how Medicare and Medicaid, as well as funding for the health law's implementation, fared in President Barack Obama's budget plan.

11 Apr 2013

European Commission blueprint on post-2015 development agenda calls for framework addressing sustainability, poverty

"The European Commission has unveiled a blueprint for global development aid and called on world leaders to replace the Millennium Development Goals with an international aid framework based on sustainable and inclusive development tackling poverty at its roots," Inter Press Service reports.

11 Apr 2013

CPAP treatment increases work productivity for people with sleep apnoea

Continuous positive airway pressure is effective at increasing work productivity, according to a new study.

11 Apr 2013

Androgen receptors found to be a potential target in breast cancer

Estrogen and progesterone receptors, and the gene HER2 - these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.

11 Apr 2013

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.

11 Apr 2013

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, has published Issue 214 of its "Global Fund Observer."

11 Apr 2013

Modulation of cerebral endocannabinoid system may help treat Fragile X chromosome syndrome

Researchers at the University of the Basque Country (UPV/EHU) and the Achucarro neurosciences centre have discovered a new therapy for the fragile X chromosome syndrome. This new therapy proposes the modulation of the cerebral endocannabinoid system in order to ameliorate the symptoms of the disease.

11 Apr 2013

Experts to discuss changes to medical ethics paradigms proposed by bioethics colleagues

Experts from across disciplines at Johns Hopkins will hold a symposium on Thursday, April 11, 2013 to discuss changes to medical ethics paradigms as proposed by their own bioethics colleagues in a recent, groundbreaking publication.

11 Apr 2013

Small, low-powered studies produce unreliable research in neuroscience

New research has questioned the reliability of neuroscience studies, saying that conclusions could be misleading due to small sample sizes.

11 Apr 2013

Abbott's ARCHITECT Galectin-3 assay earns CE mark

Abbott today announced CE Marking (Conformite Europeenne) for the ARCHITECT Galectin-3 assay, a test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure.

11 Apr 2013

Further research needed into therapeutic potential of rTMS for focal hand dystonia

Repetitive transcranial magnetic stimulation (rTMS) is being increasingly explored as a therapeutic tool for movement disorders associated with deficient inhibition throughout the central nervous system. This includes treatment of focal hand dystonia (FHD), characterized by involuntary movement of the fingers either curling into the palm or extending outward.

11 Apr 2013

Gold nano-bullets to defeat cancer

Cutting edge research into an experimental therapy that deploys nano-particles of gold in the fight against cancer earned an Alberta high school student, 16, top national honours today in the 2013 "Sanofi BioGENEius Challenge Canada" (SBCC).

11 Apr 2013

$15B commitment to Global Fund would change the course of history

On Monday "in Brussels, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an appeal to government and private sector donors for $15 billion for the next three years," Joyce Banda, president of the Republic of Malawi, writes in the Huffington Post's "The Big Push" blog.

11 Apr 2013

Decisions people make after being diagnosed with major health issue may lead to higher health risks

It may seem counter-intuitive to take health advice from a marketing professor, but when it comes to analyzing consumer data and its relationship to managing health issues such as diabetes, one University of Alberta researcher may have the right prescription.

11 Apr 2013

OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today summarized new data highlighting the progress of OncoMed's pipeline of anti-cancer biologics presented this week in an oral presentation and five posters at the Annual Meeting of the American Association of Cancer Research in Washington, DC.

11 Apr 2013

Virginia Tech scientists provide new evidence that biofilms are at work in survival of Salmonella

Virginia Tech scientists have provided new evidence that biofilms - bacteria that adhere to surfaces and build protective coatings - are at work in the survival of the human pathogen Salmonella.

11 Apr 2013